Table 20-1. Exfoliated markers for the detection of bladder cancer
| Table 20-1. Exfoliated markers for the detection of bladder cancer. | ||||
| Marker | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) |
| Cytology | 35-61 | 93-100 | - | - |
| BTA | 28-100 | 40-96 | 33-80 | 52-94 |
| NMP22 | 47-100 | 61-99 | 29-65 | 60-100 |
| BTA stat | 57-83 | 33-95 | 20-56 | 70-95 |
| BTA TRAK | 62-78 | 51-98 | 62 | 73 |
| Lewis X antigen | 80-97 | 73-86 | 72-81 | 83-98 |
| Telomerase | 62-80 | 60-99 | 84 | 89 |
| FDP | 33-83 | 66-91 | 79 | 78 |
| Cytoberatin 20 | 91 | 85 | 95 | 76 |
| Quantiant | 45-59 | 71-93 | - | - |
| Hyaluronic acid | 92 | 93 | - | - |
| Hyaluronidase | 100 | 89 | - | - |
| BLCA-4 | 96 | 100 | - | - |
| Flow cytometry | 45-72 | 80-87 | - | - |
| FDP, fibrinogen/fibrin degradation products; PPV, positive predictive value; NPV, negative predictive value. | ||||